Clinical Trials Browser

Phase 1 × Meningioma × Magnetic Resonance Spectroscopy × Clear all

NCT06650163 2026-02-05

Zr-89 Crefmirlimab Berdoxam and Immuno-Positron Emission Tomography for the Imaging of Patients With Resectable Brain Tumors

Phase 1 Recruiting

Brain Neoplasms, Glioma, Meningioma

NCT03953131 2023-09-01

Gallium Ga 68-DOTATATE PET/CT in Predicting Tumor Growth in Patients With Meningiomas

Phase 1 Completed

Meningioma